fc receptor family proteins - biocat gmbh · acrobiosystems fc receptor family proteins the...

1
ACROBIOSYSTEMS Fc Receptor Family Proteins The ecacy of a therapeuc anbody not only depends on the Fab fragment and its binding acvity to the target angen, but also depends on the Fc fragment and its interacon with key Fc receptors. The binding affinity of the Fc fragment towards FcRn (FCGRT&B2M) would predict the anbody’s half life, while that between the Fc fragment and FCGRIIIA (CD16a) would inuence the anbody’s ability to elicit ADCC (anbody dependent cell mediated cytotoxicity). Hence, screening for desired binding affinity to these Fc receptors is an essenal component in the development of a therapeuc mAb (monoclonal anbody). Acrobiosystems oers a comprehensive collecon of recombinant Fc receptor proteins, including their common variants, to help expedite your mAb development. These products have the following features that make them uniquely suitable for pharmaceucal research. Human Cell-Expressed High Purity & High Quality Binding Acvity Validated Catalog# Species Product Name FCM-H5286 Human FcRn/FCGRT & B2M Heterodimer Protein HOT! FCM-H82W4 Human Bionylated FcRn/FCGRT&B2M Heterodimer Protein HOT! FCM-M52W2 Mouse FcRn/FCGRT&B2M Heterodimer Protein FCM-R5287 Rat FcRn/FCGRT&B2M Heterodimer Protein FCM-C5284 Cynomolgus FcRn/FCGRT&B2M Heterodimer Protein CDA-H5220 Human FCGR3A/CD16a (F158) Protein CD8-H52H4 Human FCGR3A/CD16a (V158) Protein CDA-H82E8 Human Bionylated FCGR3A/CD16a (F158) Protein CDA-H82E9 Human Bionylated FCGR3A/CD16a (V158) Protein CDB-H5222 Human Fc gamma RIIIB/CD16b Protein CD3-H5249 Human CD23/Fc epsilon RII Protein CD1-H5223 Human FcGR2A/CD32a (H131) Protein CDA-H5221 Human FcGR2A/CD32a (R131) Protein CDA-H82E6 Human Bionylated FcGR2A/CD32a (H131) Protein CDB-H5228 Human Fc gamma RIIB/CD32b Protein FCA-H52H2 Human Fc gamma RI/CD64 Protein CD4-M5227 Mouse Fc gamma RI/CD64 Protein CD4-M52E8 Mouse Bionylated Fc gamma RI/CD64 Protein Immobilized human FcRn (FCM-H5286) can bind human IgG1 with an anity constant of 1 μM as determined in an SPR assay (Biacore 2000). The data is generally provided by Bian GmbH &Co KG, Germany. Immobilized Hercepn (Human IgG1) at 5 μg/mL (100 μL/well) can bind human FcRn (FCM-H5286) with a linear range of 0.2-5 μg/ml as determined in a funconal ELISA. www.biocat.com The purity of human FcRn (FCM-H5286) was greater than 95% as determined in a HPLC analysis. All our proteins are produced in HEK293 cells, which ensures the authenc post- translaonal modicaon essenal for their binding acvies. To meet the high purity requirement of pharmaceucal applicaons, all proteins have to go through both SDS-PAGE and HPLC analyses. Only those meeng all requirements will be issued a lot-specic cercate of assurance and be released. The binding acvity of our Fc receptors have been thoroughly evaluated by both SPR and ELISA analyses prior to launch. Bionylated Proteins Available The use of bion labeling can make your assay development much easier. We oer a variety of ready-to-use bionylated Fc receptors (marked in red in the table below). These proteins are produced using our in-house developed labeling techniques, which confers high bioacvity and minimal batch -to-batch variation .

Upload: others

Post on 16-Oct-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Fc Receptor Family Proteins - BioCat GmbH · ACROBIOSYSTEMS Fc Receptor Family Proteins The efficacy of a therapeutic antibody not only depends on the Fab fragment and its binding

ACROBIOSYSTEMS

Fc Receptor Family Proteins

The efficacy of a therapeutic antibody not only depends on the Fab fragment and its binding activity to the target antigen, but also depends on the Fc fragment and its interaction with key Fc receptors. The binding affinity of the Fc fragment towards FcRn (FCGRT&B2M) would predict the antibody’s half life, while that between the Fc fragment and FCGRIIIA (CD16a) would influence the antibody’s ability to elicit ADCC (antibody dependent cell mediated cytotoxicity). Hence, screening for desired binding affinity to these Fc receptors is an essential component in the development of a therapeutic mAb (monoclonal antibody). Acrobiosystems offers a comprehensive collection of recombinant Fc receptor proteins, including their common variants, to help expedite your mAb development. These products have the following features that make them uniquely suitable for pharmaceutical research.

Human Cell-Expressed High Purity & High Quality Binding Activity Validated

Catalog# Species Product Name FCM-H5286 Human FcRn/FCGRT & B2M Heterodimer Protein HOT!

FCM-H82W4 Human Biotinylated FcRn/FCGRT&B2M Heterodimer Protein HOT!

FCM-M52W2 Mouse FcRn/FCGRT&B2M Heterodimer Protein FCM-R5287 Rat FcRn/FCGRT&B2M Heterodimer Protein FCM-C5284 Cynomolgus FcRn/FCGRT&B2M Heterodimer Protein CDA-H5220 Human FCGR3A/CD16a (F158) Protein CD8-H52H4 Human FCGR3A/CD16a (V158) Protein CDA-H82E8 Human Biotinylated FCGR3A/CD16a (F158) Protein CDA-H82E9 Human Biotinylated FCGR3A/CD16a (V158) Protein CDB-H5222 Human Fc gamma RIIIB/CD16b Protein CD3-H5249 Human CD23/Fc epsilon RII Protein CD1-H5223 Human FcGR2A/CD32a (H131) Protein CDA-H5221 Human FcGR2A/CD32a (R131) Protein CDA-H82E6 Human Biotinylated FcGR2A/CD32a (H131) Protein CDB-H5228 Human Fc gamma RIIB/CD32b Protein FCA-H52H2 Human Fc gamma RI/CD64 Protein CD4-M5227 Mouse Fc gamma RI/CD64 Protein CD4-M52E8 Mouse Biotinylated Fc gamma RI/CD64 Protein

Immobilized human FcRn (FCM-H5286) can bind human IgG1 with an affinity constant of 1 μM as determined in an SPR assay (Biacore 2000). The data is generally provided by Biaffin GmbH &Co KG, Germany.

Immobilized Herceptin (Human IgG1) at 5 μg/mL (100 μL/well) can bind human FcRn (FCM-H5286) with a linear range of 0.2-5 μg/ml as determined in a functional ELISA.

www.biocat.com

The purity of human FcRn (FCM-H5286) was greater than 95% as determined in a HPLC analysis.

All our proteins are produced in HEK293 cells, which ensures the authentic post-translational modification essential for their binding activities.

To meet the high purity requirement of pharmaceutical applications, all proteins have to go through both SDS-PAGE and HPLC analyses. Only those meeting all requirements will be issued a lot-specific certificate of assurance and be released.

The binding activity of our Fc receptors have been thoroughly evaluated by both SPR and ELISA analyses prior to launch.

Biotinylated Proteins Available

The use of biotin labeling can make your assay development much easier. We offer a variety of ready-to-use biotinylated Fc receptors (marked in red in the table below). These proteins are produced using our in-house developed labeling techniques, which confers high bioactivity and minimal batch -to-batch variation .